MacroGenics, Inc. (MGNX)

MacroGenics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-9.06	-119.76	-202.12	-129.74	-151.81
Depreciation & Amortization	13.13	15.21	13.95	11.96	12.31
Share-Based Compensation	18.37	20.44	23.13	20.68	19.57
Other Operating Activities	-100.65	-2.85	21.21	-14.79	-14.34
Operating Cash Flow	-78.21	-86.96	-143.83	-111.9	-134.27
Capital Expenditures	-1.7	-3.62	-6.2	-5.91	-4.29
Change in Investments	-78.38	74.34	-30.41	-1.88	-75.07
Investing Cash Flow	-80.08	70.72	-36.61	-7.79	-79.36
Share Issuance / Repurchase	1.17	1.66	122.78	174.34	119.97
Debt Issued / Paid	149.5	0	0	0	0
Other Financing Activities	-0.31	-	-	-	-
Financing Cash Flow	150.36	1.66	122.78	174.34	119.97
Net Cash Flow	-7.93	-14.59	-57.66	54.66	-93.66
Free Cash Flow	-79.91	-90.58	-150.03	-117.8	-138.56
Free Cash Flow Margin	-136.01%	-59.62%	-193.72%	-112.32%	-215.86%
Free Cash Flow Per Share	-1.29	-1.47	-2.50	-2.25	-2.88

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).